Accelerate Diagnostics Inc. Daily Stock Analysis

Daily Stock Analysis, AXDX, Accelerate Diagnostics Inc, priceseries

Accelerate Diagnostics Inc. Daily Stock Analysis
Stock Information
Open
2.37
Close
2.45
High
2.50
Low
2.30
Previous Close
2.34
Daily Price Gain
0.11
YTD High
5.31
YTD High Date
Jan 3, 2022
YTD Low
2.22
YTD Low Date
Mar 4, 2022
YTD Price Change
-2.70
YTD Gain
-52.43%
52 Week High
10.09
52 Week High Date
Mar 10, 2021
52 Week Low
2.22
52 Week Low Date
Mar 4, 2022
52 Week Price Change
-6.33
52 Week Gain
-72.10%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 8. 2017
22.38
Mar 6. 2017
25.38
17 Trading Days
13.44%
Link
LONG
Nov 14. 2017
19.45
Dec 14. 2017
27.64
21 Trading Days
42.13%
Link
LONG
Jun 8. 2018
20.85
Jun 27. 2018
22.80
13 Trading Days
9.35%
Link
LONG
Jan 4. 2019
13.03
Jan 29. 2019
17.41
16 Trading Days
33.62%
Link
LONG
Jun 15. 2020
10.10
Jul 23. 2020
16.32
27 Trading Days
61.57%
Link
LONG
Dec 31. 2020
7.58
Jan 20. 2021
8.46
12 Trading Days
11.63%
Link
LONG
Jan 22. 2021
8.78
Jan 28. 2021
10.88
4 Trading Days
23.97%
Link
LONG
Feb 3. 2021
10.89
Feb 18. 2021
12.22
10 Trading Days
12.24%
Link
LONG
May 27. 2021
7.20
Jun 16. 2021
8.31
13 Trading Days
15.36%
Link
Company Information
Stock Symbol
AXDX
Exchange
NasdaqCM
Company URL
http://www.acceleratediagnostics.com
Company Phone
303-863-8088
CEO
Lawrence L. Mehren
Headquarters
Arizona
Business Address
3950 S. COUNTRY CLUB ROAD #470, BUILDING 3-307, TUCSON, AZ 85714
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0000727207
About

Accelerate Diagnostics, Inc. is an in vitro diagnostics company which provides solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

Description

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States. It offers Accelerate Pheno system, an vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading